CHEBI:72324 - alogliptin benzoate

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name alogliptin benzoate
ChEBI ID CHEBI:72324
Definition A benzoate salt obtained by combining equimolar amounts of alogliptin and benzoic acid. Used for treatment of type 2 diabetes.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formulae C18H21N5O2.C7H6O2
C25H27N5O4
Net Charge 0
Average Mass 461.51300
Monoisotopic Mass 461.20630
InChI InChI=1S/C18H21N5O2.C7H6O2/c1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19;8-7(9)6-4-2-1-3-5-6/h2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3;1-5H,(H,8,9)/t15-;/m1./s1
InChIKey KEJICOXJTRHYAK-XFULWGLBSA-N
SMILES OC(=O)c1ccccc1.Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O
Roles Classification
Biological Role(s): EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor
An EC 3.4.14.* (dipeptidyl- and tripeptidyl-peptidases) inhibitor that specifically inhibits dipeptidyl peptidase-4 (EC 3.4.14.5).
Application(s): hypoglycemic agent
A drug which lowers the blood glucose level.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing alogliptin benzoate (CHEBI:72324) has part alogliptin(1+) (CHEBI:72326)
alogliptin benzoate (CHEBI:72324) has role EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor (CHEBI:68612)
alogliptin benzoate (CHEBI:72324) has role hypoglycemic agent (CHEBI:35526)
alogliptin benzoate (CHEBI:72324) is a benzoate salt (CHEBI:72325)
IUPAC Names
(3R)-1-[3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl]piperidin-3-aminium benzoate
2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile benzoate
Synonyms Sources
6-((3R)-3-aminopiperidin-1-yl)-1-(2-cyanobenzyl)-3-methylpyrimidin-2,4(1H,3H)-dione monobenzoate ChemIDplus
alogliptin monobenzoate ChEBI
SYR 322 ChemIDplus
SYR-322 ChemIDplus
Brand Name Source
Nesina ChEBI
Manual Xrefs Databases
Alogliptin Wikipedia
D06553 KEGG DRUG
EP1586571 Patent
EP1970063 Patent
US2007066635 Patent
WO2010109468 Patent
WO2011141903 Patent
View more database links
Registry Numbers Types Sources
12413070 Reaxys Registry Number Reaxys
850649-62-6 CAS Registry Number KEGG DRUG
850649-62-6 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
18499100 PubMed citation Europe PMC
19427871 PubMed citation Europe PMC
19455266 PubMed citation Europe PMC
20883057 PubMed citation Europe PMC
21233588 PubMed citation Europe PMC
21431099 PubMed citation Europe PMC
22296609 PubMed citation Europe PMC
22512582 PubMed citation Europe PMC
Last Modified
11 February 2013